478 related articles for article (PubMed ID: 22797360)
41. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
42. Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.
Berndt A; Büttner R; Gühne S; Gleinig A; Richter P; Chen Y; Franz M; Liebmann C
Exp Cell Res; 2014 Apr; 322(2):402-14. PubMed ID: 24394543
[TBL] [Abstract][Full Text] [Related]
43. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
44. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells.
Cheng JC; Chang HM; Leung PC
Oncogene; 2013 Feb; 32(8):1041-9. PubMed ID: 22508482
[TBL] [Abstract][Full Text] [Related]
45. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
[TBL] [Abstract][Full Text] [Related]
46. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
[TBL] [Abstract][Full Text] [Related]
47. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
Chin LH; Hsu SP; Zhong WB; Liang YC
Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
[TBL] [Abstract][Full Text] [Related]
48. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
[TBL] [Abstract][Full Text] [Related]
49. miR-199a-5p suppresses epithelial- mesenchymal-transition in anaplastic thyroid carcinoma cells via targeting Snail signals.
Hao F; Bi YN; Wang L; Wang Y; Ma J; Cui P; Li X; Sun S; Ning L; Huang Y; Jiao X; Chen D
Cancer Biomark; 2020; 29(3):317-326. PubMed ID: 32716347
[TBL] [Abstract][Full Text] [Related]
50. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.
Fukuda S; Nishida-Fukuda H; Nanba D; Nakashiro K; Nakayama H; Kubota H; Higashiyama S
Sci Rep; 2016 Feb; 6():20209. PubMed ID: 26831618
[TBL] [Abstract][Full Text] [Related]
51. Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.
Stewart TA; Azimi I; Brooks AJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
Int J Biochem Cell Biol; 2016 Jul; 76():64-74. PubMed ID: 27163529
[TBL] [Abstract][Full Text] [Related]
52. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
Lim WC; Kim H; Ko H
J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
[TBL] [Abstract][Full Text] [Related]
53. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
54. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
55. MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
Tang Y; Wang Y; Chen Q; Qiu N; Zhao Y; You X
Int J Clin Exp Pathol; 2015; 8(9):11224-9. PubMed ID: 26617846
[TBL] [Abstract][Full Text] [Related]
56. [Epithelial-mesenchymal transition induces cancer stem cell generation in human thyroid cancer cells in vitro].
Lan L; Luo Y; Cui D; Shi BY; Deng W; Huo LL; Chen HL; Zhang GY; Deng LL
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1261-5. PubMed ID: 23902621
[TBL] [Abstract][Full Text] [Related]
57. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
[TBL] [Abstract][Full Text] [Related]
58. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.
Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J
Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045
[TBL] [Abstract][Full Text] [Related]
59. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
Zhao YL; Yuan BQ; Shen GS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
